4.7 Review

Molecular imaging of hypoxia with radiolabelled agents

Related references

Note: Only part of the references are listed.
Article Oncology

Reproducibility of intratumor distribution of F-18-fluoromisonidazole in head and neck cancer

Sadek A. Nehmeh et al.

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2008)

Article Oncology

Dependence of FDG uptake on tumor microenvironment

A Pugachev et al.

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2005)

Article Radiology, Nuclear Medicine & Medical Imaging

Preclinical validation of the hypoxia tracer 2-(2-nitroimidazol-1-yl)-N-(3,3,3-[18F]trifluoropropyl)acetamide, [18F]EF3

P Mahy et al.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2004)

Article Radiology, Nuclear Medicine & Medical Imaging

In vivo assessment of tumor hypoxia in lung cancer with 60Cu-ATSM

F Dehdashti et al.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2003)

Article Radiology, Nuclear Medicine & Medical Imaging

[18F]FMISO and [18F]FDG PET imaging in soft tissue sarcomas:: correlation of hypoxia, metabolism and VEGF expression

JG Rajendran et al.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2003)

Article Radiology, Nuclear Medicine & Medical Imaging

Noninvasive imaging of tumor hypoxia in rats using the 2-nitroimidazole 18F-EF5

LS Ziemer et al.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2003)